Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-028076

Chief Commercial Officer acquired 34,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gayer Charles K · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-19 Grant or award : show line 1 in the form +34,000 245,610 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-19 Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) +158,500 158,500 D
Loading xslF345X03/form4.xml…